A comprehensive evaluation of gene expression-based signatures for detecting tertiary lymphoid structures (TLS) in metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting Abstract from the ...

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers Halle (Saale) / Munich, Germany, February 19, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150 ...

After collecting tens of millions of dollars from San Gabriel Valley investors, Dr. Tin-Jon "T.J." Syiau made a shocking ...

Eledon Pharmaceuticals Inc.’s drug tegoprubart played a key role in the success of the second-ever kidney transplant from a ...

It is a serious condition, but it can be treated. With proper treatment, most people can survive an episode without long-term consequences. The kidney monitors the amount of fluid, electrolytes, and ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...

Anna Windle, Novo Nordisk’s Senior Vice President of Clinical Development, Medical & Regulatory Affairs, said in a news release, “Chronic kidney disease is very serious and common in patients ...

“We believe this work can form a foundation for the development of neoantigen vaccines in kidney cancer,” said Braun.